Open AccessTricyclic antidepressants and the brugada syndrome: An example of brugada waves appearing after the administration of desipramine
Author(s) -
Babliaros Vasilis C,
Hurst J. Willis
Publication year - 2002
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4950250809
Subject(s) - brugada syndrome , tricyclic , medicine , j wave , desipramine , bundle branch block , cardiology , sudden cardiac death , sudden death , anesthesia , electrocardiography , pharmacology , antidepressant , hippocampus
Since its initial description in the early 1990s, the Brugada syndrome has become increasingly familiar to active researchers and practicing clinicians. The Brugada wave, a characteristic electrocardiographic abnormality of downsloping ST‐segment elevation in leads V 1 ‐V 3 and right bundle‐branch block morphology, has Now been associated with an increased risk of sudden death. Currently, very little is known about the relationship between the Brugada syndrome and tricyclic antidepressants. Accordingly, we report the case of a patient who developed prominent Brugada waves with the administration of increasing doses of desipramine. We believe the mechanism of Brugada wave augmentation or production secondary to tricyclic antidepressants is consistent with the current model of early repolarization. We also speculate that the increased risk of sudden death that may occur with tricyclic antidepressants could be related to the development of the Brugada syndrome. We advocate the judicious use of tricyclic antidepressants in cardiac and elderly patients, with careful monitoring of the electrocardiogram for the development Brugada waves.